ChartMill assigns a Buy % Consensus number of 86% to EGRX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-09 | Piper Sandler | Downgrade | Neutral -> Underweight |
7 analysts have analysed EGRX and the average price target is 17.34 USD. This implies a price increase of 710.28% is expected in the next year compared to the current price of 2.14.
The consensus rating for EAGLE PHARMACEUTICALS INC (EGRX) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.